Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-05-24
2005-05-24
Killos, Paul J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S024000, C560S027000
Reexamination Certificate
active
06897236
ABSTRACT:
The present invention relates to compounds of formula (I) wherein R1, R2and R3independently represent one or more, same or different substituents selected from the group consisting of hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, carbamoyl, or phenyl; R1and R2further represented by nitro and R3by carboxy; R4represents hydrogen, (C1-C3)alkyl, or allyl; Q represents a bond, or —C(R6)(R7)(—O—C═O)—, in which formula R6and R7independently represent hydrogen, trifluoromethyl, or (C1-C4)alkyl; Y represents either (C5-C15)alkyl, (C2-C15)olefinic group, (C3-C10)monocyclic hydrocarbon, or phenyl, any of which may be optionally substituted with one or more, same or different substituents represented by the formula R5; or (C1-C4)alkyl substituted with at least one or more substituents with the formula R5; or Y represents a group of formula —CH2—(Z—O)n—Z where Z is a (C1-C3)alkyl, where n is a integer>1 and no continuous linear sequence of atoms in the group Y>15; R5represents halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, azido, nitro, —COOH, —CONH2, —CONHR′, or —COONR′R′ wherein R′ stands for (C1-C3)alkyl; X represents oxygen or sulphur, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compounds are valuable in the human and veterinary therapy.
REFERENCES:
patent: 9832730 (1998-07-01), None
Dannacher Heinz Wilhelm
Ottosen Erik Rytter
Killos Paul J.
Leo Pharmaceutical Products Ltd.
LandOfFree
Aminobenzophenones as inhibitors of IL-1β and TNF-α does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminobenzophenones as inhibitors of IL-1β and TNF-α, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminobenzophenones as inhibitors of IL-1β and TNF-α will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390103